DEA Targets Synthetic 7-OH Products With Schedule I Proposal
The DEA’s proposal would classify concentrated synthetic 7-OH products as Schedule I drugs, while leaving most botanical kratom outside the ban. Medscape Medical News
Read the full articleYou might also wanna read
DEA Moves to Temporarily Ban Opioid-Like Kratom Compound 7-OH as Schedule I Drug
The federal agency says it will temporarily schedule the drug, which has been called “gas station heroin,” as a controlled substance—a boon
Wired·8d ago
DEA Moves to Temporarily Ban Kratom-Derived Compounds, Classifying Them Alongside Heroin
The DEA announced it would seek to temporarily ban compounds derived from the herbal stimulant.
Rolling Stone·22h ago
Kratom advocates split as 7-OH concentrates spark internal battle, drawing RFK Jr. into the fray
Both kratom and one of its active components, 7-OH, have opioid-like effects and are widely available across the US. As health secretary RFK
Wired·25d ago
Trump administration's kratom ban benefits rival supplement makers who lobbied for the change
In moving to ban a potent synthetic version of kratom, the president’s team paved the way for more sales for makers of rival botanic supplem
nytimes.com·8d ago
US Justice Department reclassifies cannabis from Schedule I to Schedule III drug
Medical marijuana was moved into a lower category of drugs in order to increase research and access.
bbc.com·2mo ago
Palm Desert Approves New Restrictions on Kratom Substance Sales
The city of Palm Desert has adopted a new ordinance aimed at regulating the sale of kratom, a plant-derived substance that has stimulant and
Comments
Sign in to join the conversation.
No comments yet. Be the first.